Latest American Antiquities (PAWS) Headlines
Post# of 370
Posted On: 03/10/2014 10:52:59 PM
Latest American Antiquities (PAWS) Headlines
Mesa Pharmacy prescription orders for February exceed $6.5 million. Sales continue to increase inline with expectations.
PR Newswire - Wed Feb 26, 10:35AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary have continued to increase inline with expectations and have generated gross revenues, excluding allowances for returns and discounts, exceeding $6.5 Million Dollars. "We are currently filling prescriptions for transdermal topical pain medications of approximately $400,000 dollars per day". Stated Andrew Do, Mesa's President and Registered Pharmacist.
The PAWS Pet Company, Inc. acquires Mesa Pharmacy. 2014 gross revenues are expected to approach $100,000,000.
PR Newswire - Thu Jan 09, 7:00AM CST
The PAWS Pet Company, Inc. (OTCQBAWS), is pleased to announce that on December 31, 2013, PAWS closed the acquisition of Mesa Pharmacy Inc. ("Mesa").
The PAWS Pet Company, Inc. to implement In-Office Dispensing Program. Expects revenues to exceed $50M in 2014
PR Newswire - Tue Nov 26, 4:00AM CST
The PAWS Pet Company, Inc. (OTCQBAWS), is pleased to announce that it intends to begin implementation of its In-Office Dispensing Program (IODP) during the first half of December 2013 through our Advanced Access Pharmacy Services, LLC (AAPS) subsidiary. Our director, Evon Midei, will head this program up. Evon has forty years of experience in the medical industry including managing pharmacies and hospitals, having served as the COO and acting CEO of St. Luke's Hospital (formerly Allentown Osteopathic Medical Center) in Allentown, Pennsylvania. Evon holds a BS in Pharmacy and an MBA from Temple University.
The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
PR Newswire - Tue Oct 29, 3:36PM CDT
The PAWS Pet Company, Inc. (OTCQBAWS), announced it has executed an agreement to acquire MESA Pharmacy, Inc. as part of its new strategy to become a dominant player in the delivery of compounded pharmaceutical products to consumers.
The PAWS Pet Company, Inc. Retires Convertible Notes.
PR Newswire - Thu Oct 17, 2:28PM CDT
The PAWS Pet Company, Inc. (OTCQBAWS), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today.
The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA
GlobeNewswire - Tue Sep 10, 6:39PM CDT
via PRWEB - The PAWS Pet Company, Inc. (OTCQBAWS) (OTCPKAWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers.
Mesa Pharmacy prescription orders for February exceed $6.5 million. Sales continue to increase inline with expectations.
PR Newswire - Wed Feb 26, 10:35AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary have continued to increase inline with expectations and have generated gross revenues, excluding allowances for returns and discounts, exceeding $6.5 Million Dollars. "We are currently filling prescriptions for transdermal topical pain medications of approximately $400,000 dollars per day". Stated Andrew Do, Mesa's President and Registered Pharmacist. The PAWS Pet Company, Inc. acquires Mesa Pharmacy. 2014 gross revenues are expected to approach $100,000,000.
PR Newswire - Thu Jan 09, 7:00AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that on December 31, 2013, PAWS closed the acquisition of Mesa Pharmacy Inc. ("Mesa"). The PAWS Pet Company, Inc. to implement In-Office Dispensing Program. Expects revenues to exceed $50M in 2014
PR Newswire - Tue Nov 26, 4:00AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that it intends to begin implementation of its In-Office Dispensing Program (IODP) during the first half of December 2013 through our Advanced Access Pharmacy Services, LLC (AAPS) subsidiary. Our director, Evon Midei, will head this program up. Evon has forty years of experience in the medical industry including managing pharmacies and hospitals, having served as the COO and acting CEO of St. Luke's Hospital (formerly Allentown Osteopathic Medical Center) in Allentown, Pennsylvania. Evon holds a BS in Pharmacy and an MBA from Temple University. The PAWS Pet Company, Inc. Executes Agreement to Acquire MESA Pharmacy, Inc. Orders expected to exceed $25 Million in 2014
PR Newswire - Tue Oct 29, 3:36PM CDT
The PAWS Pet Company, Inc. (OTCQB
AWS), announced it has executed an agreement to acquire MESA Pharmacy, Inc. as part of its new strategy to become a dominant player in the delivery of compounded pharmaceutical products to consumers. The PAWS Pet Company, Inc. Retires Convertible Notes.
PR Newswire - Thu Oct 17, 2:28PM CDT
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today. The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA
GlobeNewswire - Tue Sep 10, 6:39PM CDT
via PRWEB - The PAWS Pet Company, Inc. (OTCQB
AWS) (OTCPKAWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers. 
(0)
(0)